Contact us
Blog
Naomi Fried, PhD
The Opportunity for Digital Innovation in Oncology Drug Development
Naomi Fried identifies three major areas where pharma faces challenges and digital innovations show promise in developing new cancer drugs and treating patients with cancer.
PharmStars featured on MobiHealthNews HIMSS TV - December 2023
On this HIMSS TV episode, host Jessica Hagan talks with Naomi Fried. Naomi, founder and CEO of PharmStars, discusses the organizations 5th cohort entitled, "digital innovations in therapeutic delivery: supply chain to the patient interface" and the 11 startups graduated from the accelerator program.
PharmStars featured on Healthcare IT News - July 2023
On this HIMSS TV episode, host Jessica Hagan talks with Naomi Fried, Founder and CEO of PharmStars. Naomi shares information about PharmStars, the pharma-focused accelerator for digital health startups.
.png)
PharmStars featured on Evermed’s Pharma Launch Secrets Podcast
On this podcast, host Bozidar Jovicevic talks with Naomi Fried, Founder and CEO of PharmStars about bridging the “Pharma-Startup Gap.”
PharmStars featured on The Shot of Digital Health Therapy Podcast
On this Shot of Digital Health Therapy podcast, hosts Jim Joyce and Eugene Borukhovich talk with Naomi Fried, Founder and CEO of PharmStars.
.png)
PharmStars featured on Healthcare IT News
On this HIMSS TV episode, host Jessica Hagan talks with Naomi Fried, Founder and CEO of PharmStars. Naomi shares information about PharmStars, the pharma-focused accelerator for digital health startups and how it helps position startups to partner successfully with the pharmaceutical industry.
PharmStars featured on the pharmaphorum podcast
On this pharmaphorum podcast, host Jonah Comstock takes us to the PharmStars presentation in November 2022 at the Boston Seaport, with interviews conducted at the event. The topic: Innovations in Real-World Evidence.
PharmStars featured on Oracle’s The Latest Dose podcast
In this episode of the Latest Dose, Naomi Fried, PhD, Founder & CEO of PharmStars and Steve Prewitt, SVP, Global Head of Digital Innovation at Sumitovant Biopharma, share the importance and significance of new entrants into the market.
Announcing PharmStars' Newest Cohort of Digital Health Startups- by the Numbers!
PharmStars featured on the Borderless Executive Live podcast
PharmStars featured on McKinsey & Co's People behind Healthcare series
PharmStars featured on the HIMSS Accelerate Health podcast
PharmStars™ Reveals Leading Pharma Companies as Founding Members
How PharmStars is different from other Accelerators
The Pharma/Digital-Health Startup Gap. What's going wrong?
A gap exists between pharma and digital health startup that prevents them from engaging in fruitful partnerships. What's going wrong?
Pharmaceutical companies and digital health startups: It’s time to get together
To advance digital health, pharmaceutical companies and start-ups should partner. There are many benefits to both from working together.
Unlocking the Exploding Field of Digital Health: A Framework for Understanding Digital Health
Digital health is new and exciting, but also fraught with complexity. We need a framework to understand how to navigate our way through the world of Digital Healthcare.
Shifts in pharma’s 2020 digital health landscape
What will 2020 and beyond bring for the digital health ecosystem?
Innovating in a Highly Regulated Industry Like Health Care
Innovating in highly regulated industries can be challenging, but it is necessary. For innovation to flourish despite legal and regulatory obstacles, we must address innovation barriers head-on.
5 criteria for calculating ROI – return on innovation – in healthcare
The ROI of digital health is more than just financial, it can take many other forms. Here are my top five.
Innovation: COVID-19's Silver Lining
2020 was not the year any of us expected, however in the world of digital health the growth of innovative solutions has been an unexpected silver lining.
